Research - St. Louis, Missouri, United States
RhoDx was founded to develop solutions to improve detection and characterization of cancer. Our three transformative technologies, NexGenAbler™, PointSuppressor™, and MethylMarker™ deliver orders of magnitude improvements to sensitivity and scalability of cell-free DNA-based liquid biopsy to enable effective, non-invasive cancer screening and monitoring.
Woo Commerce
Outlook
WordPress.org
Google Tag Manager
Google Font API
Mobile Friendly